RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $8,355,000 | -20.3% | 931,488 | -52.3% | 0.02% | -21.1% |
| Q2 2016 | $10,478,000 | +22.7% | 1,951,155 | +5.1% | 0.02% | +26.7% |
| Q1 2016 | $8,539,000 | -30.2% | 1,856,267 | -21.1% | 0.02% | -16.7% |
| Q4 2015 | $12,234,000 | -20.8% | 2,352,623 | -7.8% | 0.02% | -21.7% |
| Q3 2015 | $15,438,000 | -58.0% | 2,551,780 | +9.6% | 0.02% | -57.4% |
| Q2 2015 | $36,778,000 | +280.1% | 2,329,161 | +161.7% | 0.05% | +260.0% |
| Q1 2015 | $9,675,000 | +122.9% | 890,030 | +115.7% | 0.02% | +150.0% |
| Q4 2014 | $4,340,000 | +22.9% | 412,562 | +12.0% | 0.01% | +20.0% |
| Q3 2014 | $3,531,000 | -29.4% | 368,205 | -14.9% | 0.01% | -28.6% |
| Q2 2014 | $4,998,000 | +118.9% | 432,692 | +89.6% | 0.01% | +133.3% |
| Q1 2014 | $2,283,000 | -43.1% | 228,270 | -26.0% | 0.00% | -40.0% |
| Q4 2013 | $4,014,000 | -13.5% | 308,305 | -0.7% | 0.01% | -28.6% |
| Q3 2013 | $4,640,000 | – | 310,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |